References
- WHO mortality database: Interactive platform visualizing mortality data. Available online: https://platform.who.int/mortality/themes/theme-details/topics/indicator-groups/indicator-group-details/MDB/breast-cancer. (accessed on 12.02.2024).
- McGale P, Taylor C. EBCTCG (Early Breast Cancer Trialists’ Collaborative Group). Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet, 2014, 383:2127–35.
- Sousa C, Cruz M, Neto A et al. Neoadjuvant radiotherapy in the approach of locally advanced breast cancer. ESMO Open, 2020, 5:e000640.
- Deng Y, Li H, Zheng Y, et al. Impact of Preoperative vs Postoperative Radiotherapy on Overall Survival of Locally Advanced Breast Cancer Patients. Front. Oncol, 2021, 11:779185.
- Manikandan D, Velusamy S, Viswanathan S, et al. Locally Advanced Breast Cancer (LABC): Real-World Outcome of Patients From Cancer Institute, Chennai. JCO Glob Oncol., 2021, 7:767-781.
- Aebi S, Karlsson P, Wapnir IL. Locally advanced breast cancer. The Breast, 2022, 62:58-62.
- Ilkhomovna KD. Morphological Features of Tumor in Different Treatment Options for Patients with Locally Advanced Breast Cancer. International Journal of Innovative Analyses and Emerging Technology, 2021, 1(2): 4–5.
- Heil J, Kuerer HM, Rauch G et al. Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges. Annals of Oncology. 2020, 31(1): 61-71.
- Kang SY, Kim YS, Kim ZK, et al. Korean Breast Cancer Society. Breast cancer statistics in Korea in 2017: data from a breast cancer registry. Journal of breast cancer. 2020, 23(2): 115.
- Choi JE, Kim Z, Park CS et al. Korean Breast Cancer Society. Breast Cancer Statistics in Korea, 2019. J Breast Cancer. 2023, 26(3):207-220.
- Lim YX, Lim ZL, Ho PJ et al. Breast cancer in Asia: incidence, mortality, early detection, mammography programs, and risk-based screening initiatives. Cancers (Basel). 2022, 14:4218.
- Eurostat. Cancer screening statistics. 2024. Available online: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Cancer_screening_statistics#Breast_cancer_screening (accessed on 11.04.2024).
- Eurostat. Self-reported last breast examination by X-ray among women by age and educational attainment level. 2022. Available online: https://ec.europa.eu/eurostat/data-browser/view/hlth_ehis_pa7e/default/table?lang=en (accessed on 11.04.2024).
- Lim YX, Lim ZL, Ho PJ et al. Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives. Cancers. 2022, 14(17):4218.
- Andreev DA, Kashurnikov AYu, Zavyalov AA. Analysis of the scope of surgical breast cancer treatment in countries with the low associated mortality-to-incidence ratio. Malignant tumours. 2021, 11(1):9-19.
- Ditscha N, Untchb M, Kolberg-Liedtkec C, et al. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020. Breast Care. 2020, 15:294–309.
- Narzieyva DF, Jonibekov JJ, Erkinova ShN. Morphological features of tumor in different treatment options for patients With Locally Advanced Breast Cancer. Middle European Scientific Bulletin, 2020, 7:105-107.
- Smolarz B, Nowak AZ, Romanowicz H. Breast Cancer—Epidemiology, Classification, Pathogenesis and Treatment. Cancers. 2022, 14(10):2569.
- Katsura C, Ogunmwonyi I, Kankam HKN et al. Breast cancer: presentation, investigation and management. British Journal of Hospital Medicine, 2022, 83(2):1-7.
- Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. The British Journal of Radiology, 2022; 95:1130.
